Electroporation introduces mRNA encoding immunostimulatory factors into antigen-presenting cells to overcome T-cell tolerance from complex manipulation.
Eliminating Cbl-b in NK cells maintains tumor-targeting capabilities during expansion, resolving the trade-off between cell quantity and functional reliability.
Engineering lymphocytes with CCR8 receptors directs cells toward CCL1 gradients, overcoming poor infiltration in adoptive cell therapy.
Humanized mouse models replace non-human primates to accelerate preclinical trials while maintaining immune response representativeness.
iTR factors revert cells to an embryonic-like state, enabling ex vivo expansion and scarless wound healing without teratoma risks.
A cell culture medium with high choline chloride content supports viable cell densities and polypeptide titers in fed-batch processes.
PiggyBac transposon vectors with inducible promoters enable high-titer antibody production while preventing metabolic burden during cell growth.
Suspended culture of sweat gland myoepithelial cells with viral vectors produces immortalized cells expressing alpha-SMA and pan-cytokeratin.
Switching culture conditions between permissive and non-permissive states resolves the contradiction between cell proliferation and morphological homogeneity.
Asparagine-glutamine dipeptides stabilize glutamine during heat sterilization, resolving instability issues in cell culture media.
Engineered protein G variants with optimized amino acid sequences capture antibody fragments lacking Fc regions, enabling efficient purification.
A dermal papilla cell reprogramming system transdifferentiates non-dermal papilla cells into induced dermal papilla cells.
Veto cells derived from gene-edited pluripotent stem cells induce donor-specific immunological tolerance.